-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
LETTER: A commentary on “A young man with acute dilated cardiomyopathy associated with methylphenidate”
Commentary
(1634) Views (467) Full article downloads
Authors: Ahmad Ghanizadeh
Published Date June 2009
Volume 2009:5 Pages 525 - 526
DOI: http://dx.doi.org/10.2147/VHRM.S5108
Ahmad Ghanizadeh1,2
1Associate Professor of Child and Adolescent Psychiatry, 2Research Center for Psychiatry and Behavioral Sciences, Shiraz University of Medical Sciences, Hafez Hospital, Shiraz, Iran
With reference to the report by Nymark and colleagues,1 there are some points that should be highlighted. There is certainly a debate over whether methylphenidate is truly safe regarding possible cardiac side effects.
Readers of this article also read:
Redefining the role of thiazolidinediones in the management of type 2 diabetes
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Management of acute attacks of hereditary angioedema: potential role of icatibant
Effectiveness of coordination exercise in improving cognitive function in older adults: a prospective study
Effect of vascular burden as measured by vascular indexes upon vascular dementia: a matched case-control study
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
